Bolt Biotherapeutics Inc.

NASDAQ: BOLT · Real-Time Price · USD
5.15
-0.29 (-5.33%)
At close: Aug 15, 2025, 3:59 PM
5.23
1.55%
After-hours: Aug 15, 2025, 04:20 PM EDT

Bolt Biotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
7.21M 10.81M 9.24M 27.38M
Short-Term Investments
40.12M 91.38M 159.64M 158.84M
Long-Term Investments
22.88M 26.41M 23.94M 85.35M
Other Long-Term Assets
1.04M 3.59M 2.59M 2.61M
Receivables
1.17M n/a n/a n/a
Inventory
n/a n/a -800K -200K
Other Current Assets
1.29M 3.52M 3.86M n/a
Total Current Assets
50.81M 105.71M 172.75M 189.16M
Property-Plant & Equipment
24.89M 24.08M 28.52M 30.6M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
48.82M 54.08M 55.06M 118.56M
Total Assets
99.63M 159.78M 227.81M 307.72M
Account Payables
1.51M 2.99M 3.59M 3.57M
Deferred Revenue
3.02M 2.2M 1.99M 2.87M
Short-Term Debt
2.25M n/a 2.39M 2.5M
Other Current Liabilities
9.08M 6.67M 2.41M 5M
Total Current Liabilities
15.86M 20.46M 23.12M 21.33M
Long-Term Debt
22.96M n/a n/a n/a
Other Long-Term Liabilities
n/a 43K 42K 210K
Total Long-Term Liabilities
26.58M 26.59M 33.18M 36.27M
Total Liabilities
42.43M 47.04M 56.3M 57.6M
Total Debt
25.21M 20.22M 22.61M 24.36M
Common Stock
n/a 1K n/a n/a
Retained Earnings
-427.4M -364.29M -295.09M -206.99M
Comprehensive Income
n/a 37K -919K -321K
Shareholders Equity
57.2M 112.74M 171.51M 250.12M
Total Investments
63M 117.79M 183.59M 244.18M